Pierre Fabre Laboratories announce granting of European marketing authorization for OBGEMSA™ in overactive bladder.

Pierre Fabre Italy United States of America Canada France Germany Spain United Kingdom New Jersey Austria

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/pierre-fabre-laboratories-announce-granting-of-european-marketing-authorization-for-obgemsa-vibegron-in-overactive-bladder-302185906.html